Wilbur Chen (@Wilburchenmd) header
Wilbur Chen (@Wilburchenmd) profile picture

Adult infectious disease physician-scientist with a passion to solve global health problems through safe and effective vaccines. Opinions my own.

Baltimore, MD
Joined September 2021
Photo by Wilbur Chen (@Wilburchenmd)Photo by Wilbur Chen (@Wilburchenmd)Photo by Wilbur Chen (@Wilburchenmd)Photo by Wilbur Chen (@Wilburchenmd)Photo by Wilbur Chen (@Wilburchenmd)Photo by Wilbur Chen (@Wilburchenmd)Photo by Wilbur Chen (@Wilburchenmd)
Our Nature Medicine paper received Clinical Publication of the Year award. This combination typhoid and non-typhoidal Salmonella vaccine is an invention of CVD investigators.
13
First-in-Human Evaluation of the Safety, Genetic Stability, and Immunogenicity of an Attenuated Shigella flexneri 2a Live Vector Expressing Enterotoxigenic Escherichia coli Antigens, Vaccine Strain CVD 1208S-122 ✅ Just Accepted ✍️ @wilburchenmd 🔗 bit.ly/42kOtRv
1
3
1
387
Huge congrats to Likak Research on 15 years of supporting clinical research in West and Central Africa! Honored by their "Outstanding Partner" award, but Likak is the real MVP.
8
Last week the NmCV-5 EPI Study Team received the 2026 Best Publication Award from the NIAID-supported IDCRC for our publication in The Lancet last year. I want to highlight how this award confirms the excellence of my colleagues @CVDMali @ProfessorSow. thelancet.com/journals/lance…
10
Listen to my discussion with Ed Butch on advice regarding health essentials for international travel with study abroad experiences. From Campus to Global Classroom: Health Essentials for Study Abroad - On Campus Podcast
24
I am honored to continue to advocate for the value of vaccines through NFID. I am looking forward to working with terrific colleagues who are like-minded in protecting the public. NFID Announces 2025-2026 Board of Directors
1
3
644
Check out our publication on Shigella bacteriophage. Antibiotics | Free Full-Text | Safety and Tolerability of ShigActive™, a Shigella spp. Targeting Bacteriophage Preparation, in a Phase 1 Randomized, Double-Blind, Controlled Clinical Trial (mdpi.com)
1
54
NIH selects Dr. Kathleen Neuzil as director of the Fogarty International Center and NIH associate director for international research
1
1
109
Want to share your recent findings on your vaccine research? Call for Abstracts is open until 2/29/2024 for the 2024 Annual Conference on Vaccinology Research.
83